Fort Lauderdale , April 15, 2016 -- DNA Brands Update on 4/20/2016 Conference call
DNA Brands Inc, would like to Inform Investors of the planned Conference call scheduled for April 20 2016.
The call will take place place on Wed April the 20th at 2pm Est.
Aside from introducing incoming management the company will address:
- Discuss the different proprietary blends and flavors of DNA Brands and possible future applications of these blends.
- Brand and product development. Utilising the existing and new products of DNA brands and the Spirits and Tea line of Accel Brands moving forward.
- Exploring different market opportunities that have been presented outside of the “Energy Drink Market”
- Paying the required retainer and bringing back key Scientists back to the company.
- Reintroducing DNA Energy drinks back into retail.
- The Joint Agreement with Accel Brabds Inc (ACLP.PK)
The call will be scheduled to last about 10-15 min. “The company also encourages investors to email the company with any potential questions one might have at the address below. The Company will address any questions that we are legally allowed to ” Stated CEO Adrian McKenzie.
The Dial in number is:
Dial-in Number:(641) 715-3580
Access Code:275-524-490
Adrian McKenzie
DNA Brands Inc.
561 654-5722


7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



